IRD stock

Opus Genetics, Inc. (IRD) financials · rev $14.2M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Opus Genetics, Inc. (IRD) rev $14.2M.

Cached annual income statement
LineFY2025FY2024
Revenue$14.2M$11.0M
Operating Income-$38.6M-$62.1M
Net Income-$49.6M-$57.5M
EPS (Diluted)-$0.80-$2.15
Cached annual balance sheet
LineFY2025FY2024
Total Assets$50.2M$36.9M
Current Assets$50.0M$36.6M
Cash & Equivalents$45.1M$30.3M
PP&E$199.0K$252.0K
Total Liabilities$34.9M$11.3M
Current Liabilities$7.78M$11.3M
Long-term Debt$1.13MN/A
Total Debt$1.13MN/A
Shareholders' Equity$15.3M$6.72M
Retained Earnings-$188.6M-$139.0M

† Total Debt: Derived from long-term debt only (no total or short-term debt stored).

Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$35.3M-$25.6M
Investing Cash FlowN/A$1.21M
Financing Cash Flow$50.0M$4.19M
These statements as JSON? API free 100/day

FAQ

What is IRD P/E and revenue?

Opus Genetics, Inc. (IRD) rev $14.2M.

What is IRD revenue?

Opus Genetics, Inc. last cached revenue is $14.2M (FY2025).

Is IRD profitable?

Opus Genetics, Inc. last cached net income is -$49.6M (FY2025).

What are IRD total assets?

Opus Genetics, Inc. last cached total assets are $50.2M (FY2025).

What is IRD free cash flow?

No cached cash-flow row for IRD yet.

Not investment advice. Cached statements, not a live tape.